Found: 32
Select item for more details and to access through your institution.
The Restricted Mean Survival Time as a Tool for Ranking Comparative Outcomes in a Narrative Review that Evaluates a Network of Randomized Trials: An Example Based on PCSK9 Inhibitors.
- Published in:
- American Journal of Cardiovascular Drugs, 2021, v. 21, n. 3, p. 349, doi. 10.1007/s40256-020-00444-8
- By:
- Publication type:
- Article
Alternative Antimicrobial Irrigation Strategies for the Treatment of Infections in Children: A Review of the Existing Literature.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 8, p. 1271, doi. 10.3390/antibiotics12081271
- By:
- Publication type:
- Article
Therapeutic Options and Outcomes for the Treatment of Children with Gram-Positive Bacteria with Resistances of Concern: A Systematic Review.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 2, p. 261, doi. 10.3390/antibiotics12020261
- By:
- Publication type:
- Article
Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant Staphylococcus aureus : A Retrospective Single-Centre Experience.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 10, p. N.PAG, doi. 10.3390/antibiotics11101377
- By:
- Publication type:
- Article
Psychiatric Disorders after Switching to Dolutegravir: A Case Report of a 59-Year-Old Virosuppressed HIV-1 Positive Woman.
- Published in:
- Case Reports in Infectious Diseases, 2020, p. 1, doi. 10.1155/2020/9708913
- By:
- Publication type:
- Article
CAR-T Treatment: Determining the Survival Gain in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- letter
The QOSMOS Study: Pharmacist-Led Multicentered Observational Study on Quality of Life in Multiple Sclerosis.
- Published in:
- Neurology International, 2021, v. 13, n. 4, p. 682, doi. 10.3390/neurolint13040065
- By:
- Publication type:
- Article
Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 6, p. 2749, doi. 10.1007/s10238-023-01036-x
- By:
- Publication type:
- Article
Best Possible Medication History Collection by Clinical Pharmacist in a Preoperative Setting: An Observational Prospective Study.
- Published in:
- Pharmacy, 2023, v. 11, n. 5, p. 142, doi. 10.3390/pharmacy11050142
- By:
- Publication type:
- Article
Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect Comparisons.
- Published in:
- Hematology Reports, 2023, v. 15, n. 4, p. 670, doi. 10.3390/hematolrep15040068
- By:
- Publication type:
- Article
Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments.
- Published in:
- Hematology Reports, 2023, v. 15, n. 1, p. 57, doi. 10.3390/hematolrep15010006
- By:
- Publication type:
- Article
Risk of hospitalization and sequelae in patients with COVID‐19 treated with 3‐day early remdesivir vs. controls in the vaccine and Omicron era: A real‐life cohort study.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 3, p. 1, doi. 10.1002/jmv.28660
- By:
- Publication type:
- Article
Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials.
- Published in:
- World Journal of Urology, 2022, v. 40, n. 11, p. 2609, doi. 10.1007/s00345-022-04143-8
- By:
- Publication type:
- Article
Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Acinetobacter baumannii Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic.
- Published in:
- Microorganisms, 2023, v. 11, n. 4, p. 984, doi. 10.3390/microorganisms11040984
- By:
- Publication type:
- Article
Axicabtagene ciloleucel in non-Hodgkin lymphoma: the restricted mean survival time as a tool for estimating progression-free life expectancy better than the median.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Pricing of innovative drugs: correlation between incremental cost and survival gain in four countries.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 4, p. 309, doi. 10.1177/1758834016644465
- By:
- Publication type:
- Article
Polypharmacy in Children with Medical Complexity: A Cross-Sectional Study in a Pediatric Palliative Care Center.
- Published in:
- Children, 2024, v. 11, n. 7, p. 821, doi. 10.3390/children11070821
- By:
- Publication type:
- Article
Early Use of Sotrovimab in Children: A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with SARS-CoV-2.
- Published in:
- Children, 2022, v. 9, n. 4, p. 451, doi. 10.3390/children9040451
- By:
- Publication type:
- Article
Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression‐free survival based on reconstructed individual patient data.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 2155, doi. 10.1002/cam4.5067
- By:
- Publication type:
- Article
Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term Survivors.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00453
- By:
- Publication type:
- Article
Heterogeneity of the Italian residency training in hospital pharmacy: a pilot study from students' perspective.
- Published in:
- Journal de Pharmacie Clinique, 2018, v. 37, n. 4, p. 225, doi. 10.1684/jpc.2018.0403
- By:
- Publication type:
- Article
Viro-Immunological, Clinical Outcomes and Costs of Switching to BIC/TAF/FTC in a Cohort of People Living with HIV: A 48-Week Prospective Analysis.
- Published in:
- Biomedicines, 2022, v. 10, n. 8, p. N.PAG, doi. 10.3390/biomedicines10081823
- By:
- Publication type:
- Article
Progression-Free and Overall Survival of First-Line Treatments for Advanced Renal Cell Carcinoma: Indirect Comparison of Six Combination Regimens.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2029, doi. 10.3390/cancers15072029
- By:
- Publication type:
- Article
Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1633, doi. 10.3390/cancers15061633
- By:
- Publication type:
- Article
Hospital Pharmacy Response to Covid-19 Pandemic in Italy: What We Learned From the First Outbreak Wave.
- Published in:
- Journal of Pharmacy Practice, 2023, v. 36, n. 1, p. 87, doi. 10.1177/08971900211023643
- By:
- Publication type:
- Article
Preparation of intravenous chemotherapy bags: evaluation of a dose banding approach in an Italian oncology hospital.
- Published in:
- Global & Regional Health Technology Assessment, 2021, v. 8, n. 1, p. 29, doi. 10.33393/grhta.2021.2202
- By:
- Publication type:
- Article
Off-label oritavancin treatment outcome and molecular characterization of a vancomycin- and linezolid-resistant Enterococcus faecium causing liver abscesses.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 689, doi. 10.1093/jac/dkad410
- By:
- Publication type:
- Article
Real-Life Experience on Dolutegravir and Lamivudine as Initial or Switch Therapy in a Silver Population Living with HIV.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 8, p. 1740, doi. 10.3390/v15081740
- By:
- Publication type:
- Article
Molnupiravir and Nirmatrelvir/Ritonavir: Tolerability, Safety, and Adherence in a Retrospective Cohort Study.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 2, p. 384, doi. 10.3390/v15020384
- By:
- Publication type:
- Article
Early Treatments of Fragile Children with COVID-19—Results of CLEVER (Children COVID Early Treatment), a Retrospective, Observational Study.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 1, p. 192, doi. 10.3390/v15010192
- By:
- Publication type:
- Article
Tisagenlecleucel in Non-Hodgkin Lymphoma: The Restricted Mean Survival Time as a Tool for Estimating Progression-Free Life Expectancy Better than the Median.
- Published in:
- 2020
- By:
- Publication type:
- Letter